Announcements Trials

Browse Landscape

Phase

Phase 1 55 Phase 1/2 32 Phase 2 28 Phase NA 11 Phase EARLY_PHASE1 7 Phase 4 3 Phase 3 3 Phase 2/3 1

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 23 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 14 Stomach Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 12 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Hematologic Neoplasms 9 Head and Neck Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Hepatocellular 9 Squamous Cell Carcinoma of Head and Neck 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Myasthenia Gravis 7 Melanoma 7 Uterine Cervical Neoplasms 6 Recurrence 6 Rectal Neoplasms 6 Neoplasms by Site 6 Neoplasms by Histologic Type 6 Lymphoma 6 Leukemia 6 Urinary Bladder Neoplasms 5 Neoplasms, Plasma Cell 5 Infections 5 Colonic Neoplasms 5

Interventions

loncastuximab tesirine 1 etoposide phosphate 1 Tubercidin 1 Rituximab 1 Immunotherapy, Adoptive 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Lymphoma, B-Cell × Clear all

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡